Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol for cardiotoxicity prevention in anthracycline chemotherapy (CONTROL)
NCT05728632Phase 3Unknown
- Start
- Jan 2019
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nebivolol in Cardiotoxicity, left ventricular dysfunction. Status: unknown.
02
Drugs
nebivolol
03
Conditions
Cardiotoxicityleft ventricular dysfunction
Beyond the preview
Go deeper on NCT05728632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05728632.